Claim Missing Document
Check
Articles

Found 1 Documents
Search

Studi Efektifitas Antiretroviral Regimen Obat Kombinasi Dosis Tetap (Tenofovir/Lamivudin/Efavirenz) Berdasarkan Peningkatan Kadar Cd4 T-Limfosit (Studi dilakukan di Intalasi Farmasi Rumah Sakit X Surabaya) Wardani, Putri Kusuma; Ulfa, Ninik Mas; Natalia, A.C Aditya
Journal of Pharmacy and Science Vol. 2 No. 1 (2017): Journal of Pharmacy and Science
Publisher : Akademi Farmasi Surabaya

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.53342/pharmasci.v2i1.62

Abstract

ABSTRAKHIV adalah virus yang secara bertahap menyerang sistem kekebalan tubuh manusia. HIV dapat menyebabkan AIDS (Acquired Immune Deficiency Syndrome) dan sel yang terinfeksi yang memiliki molekul Cluster of Differentiation 4 (CD4). Pengobatan dengan antiretroviral memiliki mekanisme tindakan untuk mencegah replikasi virus yang secara bertahap menurunkan jumlah virus dalam darah. Penelitian ini observasional yang dilakukan secara retrospektif selama 2 tahun (Januari 2014 - Desember 2015) pada pasien HIV / AIDS denganjumlah 51 pasien rawat jalan. Hasil studi observasional menunjukkan bahwa pengobatan dengan antiretroviral regimen obat kombinasi dosis tetap (Tenofovir 300 mg + Lamivudin 300 mg + Efavirenz 600 mg) mengalami peningkatan jumlah CD4 selama terapi dan analisis statistik deskriptif menunjukkan bahwa ada perbedaansebelum dan sesudah terapi, sehingga dapat disimpulkan bahwa antiretroviral regimen obat kombinasi dosis tetap efektif.Kata Kunci: HIV / AIDS, CD4 T-Limfosit, Tenofovir, Lamivudin, Efavirenz.ABSTRACTHIV is a virus that gradually attack the human immune system. HIV can lead to the AIDS (Acquired Immune Deficiency Syndrome) and infected cells that have molecul Cluster of Differentiation 4 (CD4). Treatment withantiretroviral have mechanism of action to prevent replication virus which is step by step decrease the amount of virus in blood. This observasional study conducted retrospectively during 2 years (Januari 2014 - December2015) againt patient HIV/AIDS with 51 outpatients. The result of the observational study showed that treatment with Antiretroviral Fixed Dose Combination (Tenofovir 300 mg + Lamivudin 300 mg + Efavirenz 600 mg) had increased CD4 level during therapy and descriptive statistic analysis showed that there was a differences in preand post theraphy, so if could be concluded that Antiretroviral Fixed Dose Combination administration was effective.Key Words: HIV/AIDS, CD4 T-Limfosit, Tenofovir, Lamivudin, Efavirenz.